{"product_id":"suplasyn-1-shot-60","title":"Suplasyn 1 Shot 60 1x 6.0 ml","description":"\u003ch2\u003eSUPLASYN® \/ SUPLASYN® 1-Shot\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eSterile Sodium Hyaluronate Solution\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHyaluronic acid is a common component of synovial fluid and plays a central role in maintaining the physiological environment of the joint.\u003c\/p\u003e\n\u003ch3\u003eComposition\u003c\/h3\u003e\n\u003cp\u003eViscoelastic solution of purified hyaluronic acid with a defined molecular weight, produced by fermentation.\u003c\/p\u003e\n\u003cp\u003eOne prefilled syringe contains:\u003c\/p\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth\u003e\u003c\/th\u003e\n\u003cth\u003eSUPLASYN\u003c\/th\u003e\n\u003cth\u003eSUPLASYN 1-Shot\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSodium hyaluronate\u003c\/td\u003e\n\u003ctd\u003e20 mg\u003c\/td\u003e\n\u003ctd\u003e60 mg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIsotonic, buffered aqueous solution\u003c\/td\u003e\n\u003ctd\u003e2 ml\u003c\/td\u003e\n\u003ctd\u003e6 ml\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch3\u003eProperties\u003c\/h3\u003e\n\u003cp\u003eHyaluronic acid is the prototype of a large group of polysaccharides (glycosaminoglycans) that are important components of all extracellular tissue structures, including cartilage and synovial fluid. The active ingredient of SUPLASYN is a hyaluronic acid of defined molecular chain length with a high degree of purity. Injection of SUPLASYN into the joint space helps normalize joint function after joint puncture.\u003c\/p\u003e\n\u003ch3\u003eIndications\u003c\/h3\u003e\n\u003cp\u003eSUPLASYN and SUPLASYN 1-Shot are indicated for the symptomatic treatment of osteoarthritis. SUPLASYN has a therapeutic effect in treating pain and improving joint function in osteoarthritis. Multiple joints can be treated simultaneously.\u003c\/p\u003e\n\u003ch3\u003eDosage and Method of Administration\u003c\/h3\u003e\n\u003cp\u003eDepending on the size of the joint, up to 6 ml is injected intra-articularly.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSUPLASYN:\u003c\/strong\u003e The usual treatment with SUPLASYN in 2 ml syringes consists of 3 injections at weekly intervals; up to 6 injections can be administered depending on the severity of the condition.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSUPLASYN 1-Shot:\u003c\/strong\u003e For single use only.\u003c\/p\u003e\n\u003cp\u003eAseptic conditions must be strictly observed. Any remaining hyaluronic acid in the prefilled syringes must be discarded. To use the prefilled syringe, remove the “Luer-lock cap,” attach a suitable needle (21-25 G recommended depending on the size of the joint), and secure it by gently twisting. \u003cstrong\u003eThe graduations on the syringe label are for orientation purposes only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003eContraindications\/Precautions\u003c\/h3\u003e\n\u003cp\u003eDo not use in patients with known hypersensitivity to the ingredients of SUPLASYN. General precautions and contraindications for intra-articular injections must be observed. Do not inject intravascularly. SUPLASYN should only be used in joints free of inflammation\/irritation, as adverse reactions are more common in patients with existing joint inflammation\/irritation.\u003c\/p\u003e\n\u003cp\u003eThere are no clinical data on the use of hyaluronic acid in children, pregnant, or breastfeeding women. Therefore, SUPLASYN should not be used in these patient groups.\u003c\/p\u003e\n\u003cp\u003eAfter injection of SUPLASYN, the treated joint should be rested for 24-48 hours. Physically strenuous activities should be avoided throughout the treatment period with SUPLASYN.\u003c\/p\u003e\n\u003cp\u003eTemporary, short-lasting pain may occur after joint injection as a result of the injection itself. Mild local reactions such as pain, warmth, overheating, redness, effusion, irritation, and swelling\/inflammation may occur in the area of the affected joint. If such symptoms occur, it is recommended to rest the affected joint and apply ice. In most patients, these symptoms resolve within a few days.\u003c\/p\u003e\n\u003cp\u003eIn rare cases, as a sign of hypersensitivity, mild local reactions such as pain, irritation, swelling\/joint inflammation, and effusion may be more pronounced and severe. In these cases, therapeutic intervention such as joint puncture may be necessary. Local adverse reactions may be accompanied by systemic reactions such as fever, chills, or circulatory reactions, and in rare cases, anaphylactic reactions may occur.\u003c\/p\u003e\n\u003cp\u003eIn extremely rare cases, rash\/itching, hives (urticaria), inflammation of the joint lining (synovitis), and a drop in blood pressure have been observed after injection of SUPLASYN. Administration should be discontinued if adverse reactions occur. Do not use SUPLASYN with instruments sterilized in quaternary ammonium salt solutions.\u003c\/p\u003e\n\u003ch3\u003eWarnings\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eKeep out of reach of children. Do not use if the blister packaging is damaged. For use by physicians only. For single use only. Any remaining contents in the syringe must be discarded. Reuse carries the risk of contamination and\/or infection or cross-infection of patients.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003ePackage Sizes\u003c\/h3\u003e\n\u003cp\u003ePackage containing 1 prefilled syringe of 2 ml or 6 ml.\u003c\/p\u003e\n\u003ch3\u003eStorage Instructions\u003c\/h3\u003e\n\u003cp\u003eStore packages between 4 °C and 25 °C. \u003cstrong\u003eProtect from frost.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWarm to room temperature before injection.\u003c\/p\u003e\n\u003ch3\u003eDate of Information Preparation\u003c\/h3\u003e\n\u003cp\u003eFebruary 2010\u003c\/p\u003e\n\u003ch3\u003eInformation Status\u003c\/h3\u003e\n\u003cp\u003eFirst edition\u003c\/p\u003e\n\u003ch3\u003eManufacturer\u003c\/h3\u003e\n\u003cp\u003eBioniche Teo.\u003cbr\u003eInverin, Co. Galway, Ireland.\u003c\/p\u003e\n\u003cp\u003e© Bioniche Pharma Group Limited, Ireland\u003cbr\u003e+49 (0)9306 904463\u003c\/p\u003e\n\u003cp\u003eCE 0473\u003c\/p\u003e","brand":"Mylan Teoranta","offers":[{"title":"Default Title","offer_id":51849421750612,"sku":"142","price":117.95,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0786\/8756\/8212\/files\/suplasyn-1-shot-60-1x-60-ml-mylan-teoranta-gelenkspritzen-stakonmed-5649656.jpg?v=1772274022","url":"https:\/\/stakonmed.com\/products\/suplasyn-1-shot-60","provider":"StakonMed","version":"1.0","type":"link"}